Logos Global Management LP

Logos Global Management LP reported 75 holdings worth US$1.92B as of Sep 30, 2026 (Form 13F/A)

As of Sep 30, 2026 · Filed Nov 19, 2026

Logos Global Management LP reported 75 holdings worth US$1.92B as of Sep 30, 2026. Largest: Praxis Precision Medicines, Inc., Revolution Medicines, Inc. and IDEAYA Biosciences, Inc. Filed Nov 19, 2026 (Form 13F/A).

Holdings
75
Value as reported
US$1.92B

The filing in full

CompanySharesValue as reported% of portfolio
Praxis Precision Medicines, Inc.425KUS$124M6.5%
Revolution Medicines, Inc.600KUS$123M6.4%
IDEAYA Biosciences, Inc.2.85MUS$109M5.7%
Erasca, Inc.5.9MUS$86.5M4.5%
Abivax SA870KUS$86.1M4.5%
CG Oncology, Inc.975KUS$69.1M3.6%
Disc Medicine, Inc.1.01MUS$66.4M3.5%
BioNTech SE650KUS$63.9M3.3%
Tango Therapeutics, Inc.2.15MUS$53.6M2.8%
Madrigal Pharmaceuticals, Inc.100KUS$50.4M2.6%
Enliven Therapeutics, Inc.1.08MUS$49.5M2.6%
Dyne Therapeutics, Inc.3MUS$48.3M2.5%
Achieve Life Sciences, Inc.5.95MUS$48.1M2.5%
Ocular Therapeutix, Inc.6MUS$46M2.4%
Dianthus Therapeutics, Inc.500KUS$44M2.3%
ArriVent BioPharma, Inc.1.35MUS$40.9M2.1%
Cogent Biosciences, Inc.1.25MUS$40M2.1%
Neurocrine Biosciences, Inc.250KUS$35.5M1.8%
Belite Bio, Inc.200KUS$34M1.8%
Axsome Therapeutics, Inc.175KUS$32.3M1.7%
Structure Therapeutics, Inc.1MUS$31.3M1.6%
Olema Pharmaceuticals, Inc.3.21MUS$27.7M1.4%
Maze Therapeutics, Inc.935KUS$25.4M1.3%
Parabilis Medicines, Inc.750KUS$24.2M1.3%
Apnimed, Inc.1.1MUS$24.1M1.3%
Trevi Therapeutics, Inc.1.45MUS$20.7M1.1%
Veradermics, Incorporated170KUS$20.6M1.1%
Vera Therapeutics, Inc.600KUS$19.4M1.0%
Odyssey Therapeutics, Inc.846KUS$18.8M0.98%
Sarepta Therapeutics, Inc.1MUS$18.2M0.95%
Immunocore Holdings plc500KUS$15.1M0.79%
Biohaven Ltd.1.1MUS$14.7M0.77%
Obsidian Therapeutics, Inc.1.07MUS$14.6M0.76%
Definium Therapeutics, Inc.350KUS$13.3M0.69%
Design Therapeutics, Inc.1MUS$12.6M0.66%
Crescent Biopharma, Inc.850KUS$12.4M0.65%
Electra Therapeutics, Inc.1MUS$11.3M0.59%
Minerva Neurosciences, Inc3.29MUS$11M0.57%
LB Pharmaceuticals Inc250KUS$9.6M0.50%
Attovia Therapeutics, Inc.391KUS$6.71M0.35%
Viking Therapeutics, Inc.200KUS$6.52M0.34%
Editas Medicine, Inc.2.22MUS$5.71M0.30%
Tonix Pharmaceuticals Holding Corp.550KUS$5.36M0.28%
Opus Genetics, Inc.1MUS$4.84M0.25%
Vogenx Inc205KUS$4.67M0.24%
Immunovant, Inc.85,000US$2.87M0.15%
Jade Biosciences, Inc.200KUS$2.81M0.15%
OnKure Therapeutics, Inc.964KUS$2.63M0.14%
TCGX Acquisition Corp.200KUS$2.5M0.13%
Unicycive Therapeutics, Inc.474KUS$2.22M0.12%
Palatin Technologies, Inc.129KUS$1.15M0.06%
JATT II Acquisition Corp100KUS$1.12M0.06%
JATT III Acquisition Corp100KUS$1.1M0.06%
Research Alliance Corporation III100KUS$1.08M0.06%
Septerna, Inc.23,548US$921K0.05%
Amanat Acquisition Corp50,000US$534K0.03%
Fractyl Health, Inc.505KUS$275K0.01%
Celldex Therapeutics, Inc.0US$00.00%
Cybin, Inc.0US$00.00%
DBV Technologies SA0US$00.00%
Sensei Biotherapeutics, Inc.0US$00.00%
Immix Biopharma, Inc.0US$00.00%
Longeveron Inc.0US$00.00%
Mineralys Therapeutics, Inc.0US$00.00%
Q32 Bio Inc.0US$00.00%
Relay Therapeutics, Inc.0US$00.00%
Replimune Group, Inc.0US$00.00%
Rhythm Pharmaceuticals, Inc.0US$00.00%
Scholar Rock Holding Corporation0US$00.00%
Summit Therapeutics Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%
Vor Biopharma Inc.0US$00.00%
Xenon Pharmaceuticals Inc.0US$00.00%
ACADIA Pharmaceuticals Inc.0US$00.00%
Aclaris Therapeutics, Inc.0US$00.00%
Amylyx Pharmaceuticals, Inc.0US$00.00%
Annexon, Inc.0US$00.00%
Arcus Biosciences, Inc.0US$00.00%
Avalo Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related